Industry Briefs

Watching Their Wallets The rankings of 1989's top 100 spenders on industrial R&D suggests that the R&D slowdown in the U.S. has begun to reach the labs of industry leaders. Technical Insights, Inc., the Englewood, N.J., firm that publishes Inside R&D, a weekly newsletter, finds in its latest annual survey that last year the top 100, headed by General Motors, increased research spending by 8.7 percent, after posting spending gains of 10.7 percent the previous year. Charles Joslin, editor ofInsid

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Watching Their Wallets The rankings of 1989's top 100 spenders on industrial R&D suggests that the R&D slowdown in the U.S. has begun to reach the labs of industry leaders. Technical Insights, Inc., the Englewood, N.J., firm that publishes Inside R&D, a weekly newsletter, finds in its latest annual survey that last year the top 100, headed by General Motors, increased research spending by 8.7 percent, after posting spending gains of 10.7 percent the previous year. Charles Joslin, editor ofInside R&D, attributes the slowdown to "a general reluctance to look that far ahead" - and to fear of rising costs that would make the firms vulnerable to takeovers. Among the biggest increases in spending was accounted for by Bristol-Myers Squibb, now spending $789 million per year and ranked number 14, thanks to the merger last year of Bristol-Myers, then ranked 35, and Squibb, 44. Bristol-Myers Squibb is now the top ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies